Patient Registry Software Industry Size

The report "Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [Profit (Pharma, Payer, Hospital), Non-profit (Govt)], and Region - Global Forecast to 2031", is projected to grow from USD 2.47 billion in 2026 and to reach USD 3.99 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 10.0% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on "Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [Profit (Pharma, Payer, Hospital), Non-profit (Govt)], and Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/patient-registry-software-market-144694594.html

The patient registry software market is experiencing growth driven by several key factors. One significant driver is the rising burden of chronic and rare diseases, as healthcare providers and research organizations increasingly rely on registries to monitor disease progression, treatment patterns, and patient outcomes over time. The growing demand for real-world evidence is further supporting market adoption by enabling pharmaceutical companies, researchers, and healthcare organizations to evaluate treatment effectiveness and support clinical research. In addition, the growing focus on patient-centered care and quality improvement is driving demand for solutions that support longitudinal patient monitoring and evidence-based decision-making. Growing investment in clinical research and post-market safety monitoring is also encouraging the use of registries to collect and analyze structured patient data. Furthermore, cloud-based platforms, electronic health record integration, and AI-enabled analytics are improving data accessibility, streamlining registry workflows, and supporting more efficient patient data management across healthcare and research settings.

“Disease registries are expected to witness the fastest growth in the patient registry software market by registry type.”

Based on registry type, the patient registry software market is segmented into disease registries and product registries. Disease registries are expected to register the fastest growth during the forecast period, driven by the rising burden of chronic and rare diseases and the growing need for long-term patient monitoring. These registries enable healthcare providers, researchers, and public health agencies to systematically collect and analyze information on disease progression, treatment patterns, and patient outcomes. Increasing demand for real-world evidence, quality improvement, and disease surveillance is encouraging organizations to expand their use of disease-specific registries. In addition, the need to evaluate treatment effectiveness, understand care variations, and support research into conditions such as cancer, cardiovascular diseases, diabetes, and rare disorders is expected to further drive adoption.

“Cloud-based models held the largest share of the patient registry software market, by deployment model.”

Based on deployment model, the patient registry software market is segmented into on-premises and cloud-based models. The cloud-based segment accounted for the largest market share in 2025, driven by the growing need for scalable, accessible platforms to manage patient data across healthcare and research settings. Cloud-based registry solutions allow healthcare providers, pharmaceutical companies, research institutions, and public health agencies to access and update registry information across multiple locations without maintaining extensive on-site infrastructure. These platforms also support collaboration, software updates, and integration with electronic health records and other healthcare data sources. The increasing focus on real-world evidence generation, longitudinal patient monitoring, and digital health transformation is further supporting cloud adoption, particularly among organizations seeking flexible registry management solutions.

“APAC is expected to witness the highest growth rate during the forecast period.”

The patient registry software market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to register the fastest growth during the forecast period, driven by the rising burden of chronic and rare diseases, expanding healthcare infrastructure, and increasing investment in digital health technologies. Countries such as China, India, and Japan are strengthening their healthcare data systems and clinical research capabilities, creating greater demand for solutions that support disease monitoring, patient outcome tracking, and real-world evidence generation. The growing adoption of electronic health records, cloud-based platforms, and interoperable healthcare systems is also improving patient data collection and management. Furthermore, government initiatives to strengthen disease surveillance and the increasing focus on healthcare quality and evidence-based decision-making are expected to support registry software adoption across the region.

The prominent players operating in the patient registry software market include IBM (US), IQVIA (US), Health Catalyst (US), Oracle (US), Optum, Inc. (US), Conduent Incorporated (US), Elekta (Sweden), Medidata (Dassault Systèmes) (France), and Dacima Software, Inc. (EvidentIQ) (Germany), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, and mergers & acquisitions to strengthen their presence in the patient registry software market.

Don’t miss out on business opportunities in Patient Registry Software Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com